SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy
Conclusions: Our results confirm the tight link between NAFLD and metabolic complications, suggesting prediabetes as a new risk factor of steatosis. SCCA-IgM does not seem to have a role in the identification and prognosis of NAFLD.Obes Facts 2019;12:291 –306
Source: Obesity Facts - Category: Eating Disorders & Weight Management Source Type: research
More News: Alcoholism | Cancer & Oncology | Carcinoma | Diabetes | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Gastrectomy | Gastroenterology | Hepatitis | Hepatocellular Carcinoma | Insulin | Laparoscopy | Liver | Liver Cancer | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Skin Cancer | Squamous Cell Carcinoma | Study | Urology & Nephrology | Weight Loss